• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Smartphone Photos to Detect Anemia

      Smartphone Photos to Detect Anemia

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

      Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

    • Radiology
      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

      Terahertz Spectroscopy to Assess Severity of Skin Burns

      Terahertz Spectroscopy to Assess Severity of Skin Burns

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Idiopathic Pulmonary Fibrosis Treatment Market Report 2022, Generate New challenges and Opportunities with Top Company Profiles – Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla

January 17th, 2022 Coherent Market Insights Releases

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by a progressive and irreversible decrease in lung function, in which the walls of the air sacs (called alveoli) become thickened and damaged. Common symptoms count fatigue, sticky nails shortness of breath, and dry cough. Some other symptoms are joint pain, muscle pain, and weight loss. Further complications count pneumonia, pulmonary embolism, heart failure, and high blood pressure.

Some of the key factors that can cause lung damage count charcoal dust, hard metal dust, asbestos fibres, environmental factors such as silica dust, Epstein-Barr virus, herpes zoster virus, and gastrointestinal acid reflux. Treatments for idiopathic pulmonary fibrosis (IPF) count lung transplantation, symptom management, pulmonary rehabilitation, and oxygen therapy. Prescribed antifibrotic drugs are nintendetinib and pirfenidone.

Request a FREE sample copy – Idiopathic Pulmonary Fibrosis Treatment market report click here: https://www.coherentmarketinsights.com/insight/request-sample/2466

Market Drivers:

The growing geriatric population is likely to significantly increase the size of the global idiopathic pulmonary fibrosis treatment market. According to a 2015 report by the National Institutes of Health (NIH), symptoms of IPF appear in the U.S. between the ages of 50 and 70. Furthermore, the increasing prevalence of idiopathic pulmonary fibrosis is also likely to drive market growth. The incidence of idiopathic pulmonary fibrosis is 13-20 per 100,000 people worldwide, according to NIH 2015 estimates.

Smoking is thought to be another reason of idiopathic pulmonary fibrosis. According to the Centres for Disease Control and Prevention (CDCP), in 2017, there were approximately 1 billion smokers worldwide. The availability of antifibrotic drugs like Pirfenidone (Esbriet) and Nintedanib (Ofev) IPF is likely to increase the revenue of the global idiopathic pulmonary fibrosis treatment market significantly. Esbriet’s worldwide sales in 2016 were US $ 753 million, according to F. Hoffmann-La Roche AG’s annual report.

Market Restraints:

Lack of availability and awareness of appropriate treatment is likely to obstruct the growth of idiopathic pulmonary fibrosis market. 54% of patients in Europe do not receive any antifibrotic treatment, according to a 2017 report by the National Center for Biotechnology Information (NCBI).

Furthermore, the misdiagnosis of IPF is likely to hamper the size of the global idiopathic pulmonary fibrosis treatment market. For example, according to Multidisciplinary Respiratory Medicines (MRM), about 50% of IPF cases misdiagnosed for other lung diseases in 2012 in the U.S. High costs linked with the treatment of idiopathic pulmonary fibrosis are also likely to obstruct growth of market. For example, the treatment for idiopathic pulmonary fibrosis costs US $ 100,000 annually, according to data published in the American Journal of Managed Care (AJMC) in 2014.

Regional Analysis:

Due to the increasing incidence of idiopathic pulmonary fibrosis, North America dominated the idiopathic pulmonary fibrosis market in 2017. According to the NIH, 2015, about 100,000 people are affected by IPF and the U.S. About 30,000 to 40,000 new patients are diagnosed with the disease each year. Furthermore, the increasing approval of new drugs is likely to boost the global idiopathic pulmonary fibrosis treatment market in this area. For example, in 2015, Prometic Life Sciences Inc. To U.S. The first orphan drug for PBI-4050 was approved by the Food and Drug Administration (FDA). Similarly, in 2017, plasminogen (Riplasim) was introduced in the U.S. It was approved by the FDA as an orphan drug.

Europe was the second largest region in the global idiopathic pulmonary fibrosis treatment market in 2017, due to the growing coverage of IPF in the region. In 2015, for example, the European Pulmonary Fibrosis Patient Charter registered about 80,000 to 111,000 people suffering from IPF, and 30,000 to 35,000 patients are diagnosed with the disease each year in Europe. The Asia-Pacific Idiopathic Pulmonary Fibrosis market is likely to grow significantly in the forecast period, as the number of people addicted to smoking in the region continues to grow. In 2017, for example, more than 30% of the world’s smokers were reported in Asia Pacific, according to World Bank figures.

š†šžš­ šŒšØš«šž šƒšžš­ššš¢š„š¬? š“ššš„š¤ š­šØ šŽš®š« š€š§ššš„š²š¬š­ @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2466

Market Segmentation:

On the basis of Drug Type:

  • Nintedanib
  • Pirfenidone

On the basis of Formulation:

  • Soft Capsules
  • Tablets

On the basis of Distribution Channel:

  • Online Pharmacy
  • Retail Pharmacy
  • Hospital Pharmacy

On the basis of Region:

  • Africa
  • Middle East
  • Asia Pacific
  • Europe
  • Latin America
  • North America

Competitive Landscape:

Key players performing in the global idiopathic pulmonary fibrosis treatment market are Prometic Life Sciences Inc., Promedior, Inc., Merck & Co., Inc., MediciNova, Inc., Galapagos NV, FibroGen, Inc., F. Hoffmann-La Roche, Cipla, Bristol-Myers Squibb Company, Boehringer Ingelheim, and Biogen.

Reasons to Buy thisĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Report

āž” Save time carrying out entry-level research by identifying the size, growth, and leading players in the emergingĀ Idiopathic Pulmonary Fibrosis TreatmentĀ market

āž”Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emergingĀ Idiopathic Pulmonary Fibrosis TreatmentĀ market

āž”Leading company profiles reveal details of keyĀ Idiopathic Pulmonary Fibrosis TreatmentĀ market players emerging five operations and financial performance

āž”Add weight to presentations and pitches by understanding the future growth prospects of the emergingĀ Idiopathic Pulmonary Fibrosis TreatmentĀ market with five year historical forecasts

āž”Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .

Buy This Complete Business ReportĀ With Flat USD 2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/2466

Table of Content

Chapter 1Ā Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5Ā Idiopathic Pulmonary Fibrosis TreatmentĀ Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak:Ā Idiopathic Pulmonary Fibrosis TreatmentĀ Industry Impact

Chapter 2Ā GlobalĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Competition by Types, Applications, and Top Regions and Countries
2.1 GlobalĀ Idiopathic Pulmonary Fibrosis TreatmentĀ (Volume and Value) by Type
2.3 GlobalĀ Idiopathic Pulmonary Fibrosis TreatmentĀ (Volume and Value) by Regions

Chapter 3Ā Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4Ā GlobalĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Sales, Consumption, Export, Import by Regions
Chapter 5Ā North AmericaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 6Ā East AsiaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 7Ā EuropeĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 8Ā South AsiaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 9Ā Southeast AsiaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 10Ā Middle EastĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 11Ā AfricaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 12Ā OceaniaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 13Ā South AmericaĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Analysis
Chapter 14Ā Company Profiles and Key Figures inĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Business
Chapter 15Ā GlobalĀ Idiopathic Pulmonary Fibrosis TreatmentĀ Market Forecast (2021-2028)
Chapter 16Ā Conclusions
Research Methodology….

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored
Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

interviews & reviews
Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStanceĀ 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStanceĀ 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
Ā© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email